Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - CLINICAL DATA INC | b84789e10vq.htm |
| EX-31.2 - EX-31.2 - CLINICAL DATA INC | b84789exv31w2.htm |
| EX-31.1 - EX-31.1 - CLINICAL DATA INC | b84789exv31w1.htm |
EXHIBIT 32.1
STATEMENT PURSUANT TO 18 U.S.C. § 1350
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Act of 1934, as
amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code
(18 U.S.C. §14350), the undersigned, Andrew J. Fromkin, Chief Executive Officer and President of
Clinical Data, Inc. (the “Company”) and C. Evan Ballantyne, Executive Vice President and Chief
Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:
(1) the Company’s Quarterly Report on Form 10-Q for the period ending December 31, 2010, to
which this certification is attached as Exhibit 32.1 (the “Report”), fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
| Date: February 9, 2011 | /s/ Andrew J. Fromkin | |||
| Andrew J. Fromkin | ||||
| President and Chief Executive Officer | ||||
| Date: February 9, 2011 | /s/ C. Evan Ballantyne | |||
| C. Evan Ballantyne | ||||
| Executive Vice President and Chief Financial Officer | ||||
This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the
Securities and Exchange Commission and is not incorporated by reference into any filing of the
Company under the Securities Exchange Act of 1933, as amended, or the Securities Exchange Act of
1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any
general incorporation language contained in such filing.